Paliperidone palmitate-induced facial angioedema: A case report

World Journal of Clinical Cases
Maytinee SrifuengfungNatee Viravan

Abstract

Paliperidone palmitate is a once-monthly injectable, atypical antipsychotic. To our knowledge, there has been only one report of paliperidone palmitate-induced angioedema presenting with acute laryngeal edema with subsequent respiratory arrest. Here, we present a case report of paliperidone palmitate-induced angioedema with a relatively mild clinical presentation compared with the previously reported case, and the patient's condition was not complicated by life-threatening anaphylaxis. A 79-year-old female, who had a major neurocognitive disorder due to Alzheimer's disease with behavioral disturbances. Paliperidone palmitate was off-label used to control her aggression, irritability, and psychosis. After induction doses (150 mg and 100 mg intramuscularly, given 1 wk apart), she developed intermittent swelling of the face, eyelids, and lips on day 17 after the initial dose, and the edema was explicitly seen on day 20. The diagnosis was paliperidone palmitate-induced angioedema. The monthly injection dose was discontinued on day 33 after the initial dose. The angioedema was subsequently alleviated, and it had completely resolved by day 40 after the initial dose. Paliperidone palmitate-induced angioedema is a rare condition and ca...Continue Reading

References

Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Nov 4, 1995·BMJ : British Medical Journal·C Cooney, A Nagy
Aug 2, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A Agostoni, M Cicardi
Apr 1, 1958·The American Journal of Psychiatry·F R HINE
Aug 6, 2009·The Journal of Clinical Psychiatry·Titus MohanRohan Dhillon
Nov 30, 2010·General Hospital Psychiatry·Ramachandran Naik SoumyaNavendu Gaur
Oct 26, 2011·Reviews on Recent Clinical Trials·Elizabeth Gilday, Henry A Nasrallah
Jul 10, 2012·The Journal of Neuropsychiatry and Clinical Neurosciences·Andrew J MuzykXavier A Preud'homme
Nov 28, 2012·Allergology International : Official Journal of the Japanese Society of Allergology·Naoko Inomata
Dec 15, 2012·Expert Review of Neurotherapeutics·Pierre Chue, James Chue
Jan 23, 2013·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Fahri GüneşTugba Canatan
Jun 10, 2014·Journal of Clinical Psychopharmacology·Zeynep Baran TatarBulent Baran
Jul 1, 2015·Journal of Clinical Psychopharmacology·Atakan YucelMurat Saritemur
Apr 30, 2017·Psychiatria polska·Marek JaremaJanusz Rybakowski
Aug 9, 2017·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Seoyoung Jang, Jungmin Woo
Oct 14, 2017·Journal of Clinical Psychopharmacology·Athanasia PapadopoulouEmmanouil N Rizos
Sep 20, 2019·The Mental Health Clinician·Gabriela D Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of Clinical Psychopharmacology
Atakan YucelMurat Saritemur
Journal of Clinical Psychopharmacology
Athanasia PapadopoulouEmmanouil N Rizos
Medizinische Monatsschrift für Pharmazeuten
Heike Oberpichler-Schwenk
Clinical Schizophrenia & Related Psychoses
Rohit MadanSriram Ramaswamy
Journal of Clinical Psychopharmacology
Frances R Frankenburg, Sabbay Malvesti
© 2021 Meta ULC. All rights reserved